|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08037 CH BIOTECH SER
Nominal 
0.415 0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -8.950% | 23.707% | 2.407% | 4.569% | -26.207% |
| ROAE (%) | -17.917% | 51.717% | 5.248% | 9.540% | -32.235% |
| Return on Capital Employed (%) | -18.980% | 27.997% | 4.044% | 4.775% | -27.243% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 16.192% | 59.462% | 57.397% | 51.706% | 37.783% |
| EBITDA Margin (%) | -36.417% | 50.593% | 40.931% | 38.063% | -146.079% |
| Pre-tax Profit Margin (%) | -66.998% | 46.601% | 28.964% | 30.925% | -185.080% |
| Net Profit Margin (%) | -45.025% | 13.939% | 3.108% | 4.601% | -166.928% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 1.638 X | 1.613 X | 1.222 X | 1.639 X | 1.608 X |
| Quick Ratio (X) | 1.580 X | 1.578 X | 1.201 X | 1.619 X | 1.544 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 25.913% | 43.793% | 34.082% | 43.359% | 24.778% |
| Total Debt / Total Assets (%) | 15.157% | 5.562% | 9.504% | 11.762% | 10.131% |
| Net Debt / Total Assets (%) | 4.274% | -0.747% | -11.798% | -30.770% | -0.795% |
| Total Debt / Shareholders' Funds (%) | 21.695% | 13.570% | 16.988% | 30.973% | 14.594% |
| Long Term Debt / Shareholders' Funds (%) | 1.238% | 10.812% | 0.899% | 24.198% | 2.104% |
| Net Debt / Shareholders' Funds (%) | 6.118% | -1.823% | -21.089% | -81.029% | -1.145% |
| Net Cash / (Debt) ($) | (28.309M) | 10.986M | 83.384M | 278.199M | 3.312M |
| Net Cash / (Debt) per share ($) | (0.029) | 0.011 | 0.087 | 0.288 | 0.003 |
| Total Debt / Capital Employed (%) | 19.964% | 8.872% | 14.012% | 16.831% | 11.633% |
| Interest Coverage Ratio (X) | N/A | 247.874 X | 28.612 X | 32.210 X | N/A |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 28.762 Day | 5.705 Day | 7.053 Day | 5.162 Day | 34.250 Day |
| Receivables Turnover (Day) | 664.332 Day | 83.193 Day | 35.825 Day | 11.522 Day | 76.203 Day |
| Payables Turnover (Day) | 182.709 Day | 21.940 Day | 60.383 Day | 53.887 Day | 17.121 Day |
| Remarks: | Real time quote last updated: 11/11/2024 09:48 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -79,917,000 |
| %Change | 162.160% |
| EPS / (LPS) | HKD -0.083 |
| NBV Per Share ($) | HKD 0.405 |